EV/EBITDA
1.18
0.000.00%
Fri, 07 Feb 2025 14:56:20 GMT
Summary
- As of February 8, 2025, EGRX EV/EBITDA is 1.18, unchanged from the previous trading day.
- Over the past year, EGRX EV/EBITDA has dropped by -0.93 (-44.08%).
- EGRX EV/EBITDA is now -99.86% below its all-time high of 823.78.
Performance
EGRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
EGRX EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | 0.0% | 0.0% | 0.0% |
1 m1 month | +4.4% | +5.1% | +45.5% |
3 m3 months | -1.7% | -1.0% | -5.9% |
6 m6 months | -40.4% | -40.2% | -81.2% |
ytdytd | +5.4% | +6.2% | +60.0% |
1 y1 year | -44.1% | -43.8% | -83.3% |
5 y5 years | -95.3% | -90.7% | -98.6% |
EGRX EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -4.1% | 1.13 | +4.4% | |
3 m | 3-month | 1.23 | -4.1% | 1.09 | +8.3% |
6 m | 6-month | 2.23 | -47.1% | 1.08 | +9.3% |
1 y | 1-year | 2.57 | -54.1% | 1.08 | +9.3% |
3 y | 3-year | 693.44 | -99.8% | 1.08 | +9.3% |
5 y | 5-year | 710.84 | -99.8% | 1.08 | +9.3% |
alltime | all time | 823.78 | -99.9% | -404.85 | +100.3% |
Eagle Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | 1.18(+5.4%) |
2024 | 1.12(-49.5%) |
2023 | 2.22(-55.6%) |
2022 | 5.00(-99.3%) |
2021 | 685.47(+3559.7%) |
2020 | 18.73(-29.7%) |
Date | Value |
---|---|
2019 | 26.64(+104.8%) |
2018 | 13.01(+39.4%) |
2017 | 9.33(-55.8%) |
2016 | 21.13(-95.6%) |
2015 | 484.58(-6067.7%) |
2014 | -8.12 |
FAQ
- What is Eagle Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Eagle Pharmaceuticals?
- What is EGRX EV/EBITDA year-to-date change?
- What is Eagle Pharmaceuticals EV/EBITDA year-on-year change?
What is Eagle Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of EGRX is 1.18
What is the all time high EV/EBITDA for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high EV/EBITDA is 823.78
What is EGRX EV/EBITDA year-to-date change?
Eagle Pharmaceuticals EV/EBITDA has changed by +0.06 (+5.36%) since the beginning of the year
What is Eagle Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, EGRX EV/EBITDA has changed by -0.93 (-44.08%)